Lataa...
SAT-493 A Case of Profound Hypothyroidism Secondary to Immune Check Point Inhibitors
Background: The discovery of immune check-point inhibitors (ICI) revolutionized cancer treatment. CTLA-4, anti-PD-1 and anti-PD-L1 monoclonal antibodies have been approved in recent years. However, the advantageous clinical outcomes can also be associated with potentially severe immune related adver...
Tallennettuna:
| Julkaisussa: | J Endocr Soc |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7209753/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.694 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|